Omeprazole, bismuth, metronidazole and tetracycline (OBMT) quadruple therapy given twice daily for H-pylori eradication in a community gastroenterology practice.

被引：1
|
作者：
Chiba, N [1 ]
Marshall, C [1 ]
机构：
[1] Surrey GI Clin, Guelph, ON, Canada
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)80369-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G0372
引用
收藏
页码：A91 / A91
页数：1
相关论文
共 50 条
  • [21] Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole, plus lansoprazole) for treatment of Helicobacter pylori infection.
    Graham, DY
    Hoffman, J
    ElZimaity, HMT
    Graham, DP
    Genta, RM
    Osato, M
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A132 - A132
  • [22] Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients:: A prospective, randomized, multicenter, North American trial
    Laine, L
    Hunt, R
    El-Zimaity, H
    Nguyen, B
    Osato, M
    Spénard, J
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (03): : 562 - 567
  • [23] Efficacy of a multistep strategy for Helicobacter pylori eradication: quadruple therapy with omeprazole, metronidazole, tetracycline and bismuth after failure of combination of omeprazole, clarithromycin and amoxycillin (vol 115, pg 617, 2000)
    Diez, JMB
    Mompo, CL
    Rams, FR
    Lareo, MG
    Ibanez, MRH
    Gila, JT
    [J]. MEDICINA CLINICA, 2000, 115 (20): : 774 - 774
  • [24] New formulation of bismuth quadruple therapy for H. pylori eradication: efficacy and safety in daily clinical practice in Italy
    Zagari, R. M.
    Romiti, A.
    Ierardi, E.
    Romano, M.
    Farinati, F.
    Savarino, E.
    Gravina, A. G.
    Eusebi, L. H.
    Bazzoli, F.
    [J]. HELICOBACTER, 2017, 22
  • [25] Twice daily (mid-day and evening) quadruple therapy for H-pylori infection in the United States
    Graham, DY
    Belson, G
    Abudayyeh, S
    Osato, MS
    Dore, MP
    El-Zimaity, HMT
    [J]. DIGESTIVE AND LIVER DISEASE, 2004, 36 (06) : 384 - 387
  • [26] Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradication
    Kim, Ji Yeon
    Lee, Sun-Young
    Kim, Jeong Hwan
    Sung, In-Kyung
    Park, Hyung Seok
    [J]. HELICOBACTER, 2020, 25 (02)
  • [27] Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori:: an international multicentre study
    O'Morain, C
    Borody, T
    Farley, A
    De Boer, WA
    Dallaire, C
    Schuman, R
    Piotrowski, J
    Fallone, CA
    Tytgat, G
    Mégraud, F
    Spénard, J
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (03) : 415 - 420
  • [28] Ranitidine bismuth citrate or omeprazole-based triple therapy for H-pylori eradication in H-pylori-infected nonulcer dyspepsia
    Chuang, CH
    Sheu, BS
    Yang, HB
    Wu, JJ
    Lin, XZ
    [J]. GUT, 2001, 49 : A93 - A93
  • [29] EFFICACY AND TOLERABILITY OF TWO QUADRUPLE REGIMENS; BISMUTH, OMEPRAZOLE, METRONIDAZOLE AND AMOXICILLIN OR TETRACYCLINE AS FIRST LINE TREATMENT FOR ERADICATION OF HELICOBACTER PYLORI IN PATIENTS WITH DUODENAL ULCER
    Salmanroghani, Hassan
    Salmanroghani, Roham
    Baghbanian, Mahmud
    Mirvakili, Seyed Masoud
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S250 - S251
  • [30] Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study
    Ergul, Bilal
    Kocak, Erdem
    Tas, Adnan
    Filik, Levent
    Koklu, Seyfettin
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (05) : 527 - 529
12345